Determining recommended acceptable intake limits for N-nitrosamine impurities in pharmaceuticals: Development and application of the Carcinogenic Potency Categorization Approach (CPCA)
Author:
Naomi L. Kruhlak,Marianne Schmidt,Roland Froetschl,Stefan Graber,Bodo Haas,Irene Horne,Stephen Horne,Sruthi T. King,Iryna A. Koval,Govindaraj Kumaran,Anja Langenkamp,Timothy J. McGovern,Tyler Peryea,Alan Sanh,Aline Siqueira Ferreira,Leon van Aerts et al.
Publication:
Regulatory Toxicology and Pharmacology
Published by Elsevier Inc.